Produkty 23132-17-4

CAS 23132-17-4 to numer rejestracyjny substancji Tetrahydrocannabinol acetate, 1 mg/mL in methanol. Oferty producentów: Biosynth. Dostępne opakowania: 5ml, 2ml.

Tetrahydrocannabinol acetate, 1 mg/mL in methanol
Biosynth
  • opakowanie: 5ml, 2ml
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] acetate (CAS 23132-17-4) to związek chemiczny o wzorze sumarycznym C23H32O3 i masie molowej 356.5 g/mol. Nazwa systematyczna IUPAC: [(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] acetate. InChIKey: DEWSJDIJFWQLOA-RTBURBONSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H32O3
Masa molowa356.5 g/mol
Nazwa IUPAC[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] acetate
InChIKeyDEWSJDIJFWQLOA-RTBURBONSA-N
SMILESCCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: THC-O-ACETATE, DRONABINOL O-ACETATE, delta9-Tetrahydrocannabinol acetate, Tetrahydrocannabinol acetate, Acetic acid, tetrahydrocannabinol ester, delta(sup 1)-THC acetate, delta(sup 1)-Tetrahydrocannabinol acetate, delta(sup 9)-Tetrahydrocannabinol acetate, THC-O-Acetate Solution, orb3021449
Izomery (ten sam wzór sumaryczny)
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate C23H32O3
[(8R,9S,13S,14S,17R)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate C23H32O3
[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] pentanoate C23H32O3
[(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C23H32O3
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 2,2,3,3,4,4,5,5,5-nonadeuteriopentanoate C23H32O3
(7R,8R,9S,13S,14S,17R)-17-ethynyl-7,13-dimethylspiro[1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C23H32O3
(8R,9S,13S,14S,17R)-13-ethyl-17-ethynylspiro[1,2,4,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C23H32O3
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-methylbutanoate C23H32O3
[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-yl] acetate C23H32O3
[(8R,9S,13S,14S,17S)-2,4,16,16-tetradeuterio-3-hydroxy-13-methyl-7,8,9,11,12,14,15,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl] pentanoate C23H32O3
3-[(3S,5R,8R,9S,10S,13R,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H32O3
[(8R,9S,10R,13S,14S,17S)-7,10,13,17-tetramethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O3